Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor

E. J. Kuipers, E. Vellenga*, J. T.M. De Wolf, B. P.C. Hazenberg

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Abstract

We report the use of granulocyte-macrophage colony stimulating factor (GM-CSF) in a case of rheumatoid arthritis with sulfasalazine induced agranulocytosis, leading to a rapid bone marrow recovery within 7 days. This case and 2 others reported in the literature emphasize the need for further research into the possible role of GM-CSF in the treatment of drug induced agranulocytosis.

Original languageEnglish
Pages (from-to)621-622
Number of pages2
JournalJournal of Rheumatology
Volume19
Issue number4
Publication statusPublished - 1992
Externally publishedYes

ASJC Scopus Subject Areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Keywords

  • agranulocytosis
  • granulocyte-macrophage colony stimulating factor
  • rheumatoid arthritis
  • sulfasalazine

Fingerprint

Dive into the research topics of 'Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor'. Together they form a unique fingerprint.

Cite this